Shaping the Future with Pompe Patients Astellas prioritizes patient input in developing innovative treatments for Pompe disease, shaping clinical trials and the overall process. Discover the impact of this approach. View more Addressing Global Health Challenges A common desire to deliver schistosomiasis treatment for young children in Africa was the driver for success in a recent collaborative milestone. Read more Financial Results for FY2024 We announced our financial results for FY2024 on April 25th. Presentation material, video, and meeting script are available. Read more From the CEO I will make every effort to navigate Astellas with speed and a sense of urgency that “our patients are waiting.” Read more Latest News Jul 17, 2025Press ReleasesAstellas Announces a Partnership with the “Korea Institute of Startup and Entrepreneurship Development”, an Umbrella Organization of a Korean Government Agency, for the Operation of the“Partnership with Global Companies Program” Jul 10, 2025Press ReleasesSales of IZERVAY™ (Preliminary Figures) Jun 13, 2025Press ReleasesMitsubishi Research Institute and Astellas Announce Collaboration to Support Pharma Startups in Japan EXPLORE ALL NEWS About us Astellas aims to stand on the forefront of healthcare change to turn innovative science into VALUE for patients. Read more R & D Strategy Astellas’ Focus Area approach supports our commitment to continuous innovation and the creation of innovative therapies that directly address the underlying causes of disease. Read more Sustainability We are developing a sustainable society by leveraging Astellas’ strengths and capabilities. Read more Partnering with Astellas We are actively seeking collaboration opportunities with external partners. Read More Careers Investor Relations Read More Astellas Pharma’s official LinkedIn We share the latest information and topics. Follow us Modern Slavery Act 2015 Contact for Potential Acquisition of Astellas’ R＆D programs.
